Mitochondrial medicine is increasingly discussed as a promising therapeutic approach, given that mitochondrial defects are thought to contribute to many prevalent diseases and their complications. In individuals with diabetes mellitus (DM), defects in mitochondrial structure and function occur in many organs throughout the body, contributing both to the pathogenesis of DM and complications of DM. Diabetic cardiomyopathy (DbCM) is increasingly recognized as an underlying cause of increased heart failure in DM, and several mitochondrial mechanisms have been proposed to contribute to the development of DbCM. Well established mechanisms include myocardial energy depletion due to impaired adenosine triphosphate (ATP) synthesis and mitochondrial uncoupling, and increased mitochondrial oxidative stress. A variety of upstream mechanisms of impaired ATP regeneration and increased mitochondrial reactive oxygen species have been proposed, and recent studies now also suggest alterations in mitochondrial dynamics and autophagy, impaired mitochondrial Ca²⁺ uptake, decreased cardiac adiponectin action, increased O-GlcNAcylation, and impaired activity of sirtuins to contribute to mitochondrial defects in DbCM, among others. In the current review, we present and discuss the evidence that underlies both established and recently proposed mechanisms that are thought to contribute to mitochondrial dysfunction in DbCM.

Citations

Citations to this article as recorded by  

• SIRT1: a promising therapeutic target in type 2 diabetes mellitus
  Ainaz Mihanfar, Maryam Akbarzadeh, Saber Ghazizadeh Darband, Shirin Sadighparvar, Maryam Majidinia
  Archives of Physiology and Biochemistry.2024; 130(1): 13.     CrossRef
• Effect of exercise on improving myocardial mitochondrial function in decreasing diabetic cardiomyopathy
  Feng Zhang, Jian jian Lin, Hao nan Tian, Jun Wang
  Experimental Physiology.2024; 109(2): 190.     CrossRef
• Cardioprotective effects of asiaticoside against diabetic cardiomyopathy: Activation of the AMPK/Nrf2 pathway
  Chennian Xu, Lin Xia, Dengyue Xu, Yang Liu, Ping Jin, Mengen Zhai, Yu Mao, Yiwei Wang, Anguo Wen, Jian Yang, Lifang Yang
  Journal of Cellular and Molecular Medicine.2024;[Epub]     CrossRef
• Mitochondrial dynamics and the significance of its disturbances in the development of childhood diseases. Part II. Cardiological and endocrinological aspects
  V. S. Sukhorukov, T. I. Baranich, A. V. Egorova, E. N. Fedorova, K. A. Skvortsova, D. A. Kharlamov, A. I. Krapivkin
  Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics).2024; 69(2): 12.     CrossRef
• Ferroptosis: Mechanisms and role in diabetes mellitus and its complications
  Pan Liu, Zhengdong Zhang, Yichen Cai, Zhaoying Li, Qian Zhou, Qiu Chen
  Ageing Research Reviews.2024; 94: 102201.     CrossRef
• Salidroside Alleviates Myocardial Ischemia Reperfusion by Balancing Mitochondrial Homeostasis via Nrf2
  Tingxu Yan, Xu Li, Xin Wang, Bosai He, Ying Jia, Wei Xiao, Rong He
  Journal of Food Biochemistry.2024; 2024: 1.     CrossRef
• AGO2 Protects Against Diabetic Cardiomyopathy by Activating Mitochondrial Gene Translation
  Jiabing Zhan, Kunying Jin, Rong Xie, Jiahui Fan, Yuyan Tang, Chen Chen, Huaping Li, Dao Wen Wang
  Circulation.2024; 149(14): 1102.     CrossRef
• Pathophysiological aspects of morphological changes in the structure of atrioventricular valves leafl ets in diabetes mellitus
  V. V. Krylov, M. R. Ragimov, I. V. Misnikova
  Clinical Medicine (Russian Journal).2024; 102(2): 109.     CrossRef
• Promoting mitochondrial dynamics by inhibiting the PINK1–PRKN pathway to relieve diabetic nephropathy
  Jun-yi Zhu, Joyce van de Leemput, Zhe Han
  Disease Models & Mechanisms.2024;[Epub]     CrossRef
• SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits
  Alberto Preda, Fabrizio Montecucco, Federico Carbone, Giovanni G Camici, Thomas F Lüscher, Simon Kraler, Luca Liberale
  Cardiovascular Research.2024; 120(5): 443.     CrossRef
• Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects
  Maria Antonietta Riemma, Elena Mele, Maria Donniacuo, Marialucia Telesca, Gabriella Bellocchio, Giuseppe Castaldo, Francesco Rossi, Antonella De Angelis, Donato Cappetta, Konrad Urbanek, Liberato Berrino
  Frontiers in Pharmacology.2024;[Epub]     CrossRef
• IL-37 ameliorates myocardial fibrosis by regulating mtDNA-enriched vesicle release in diabetic cardiomyopathy mice
  Qingyu Huang, Tongqing Chen, Jian Li, Yiming Wang, Huairui Shi, Yifei Yu, Qingwei Ji, Xiaoyan Shen, Tao Sun, Haiming Shi, Xinping Luo, Bo Jin, Yan You, Bangwei Wu
  Journal of Translational Medicine.2024;[Epub]     CrossRef
• Lysophosphatidylcholine trigger myocardial injury in diabetic cardiomyopathy via the TLR4/ZNF480/AP-1/NF-kB pathway
  Nannan Liu, Yang Chen, Tian An, Siyu Tao, Bohan Lv, Jinfang Dou, Ruxue Deng, Xianjie Zhen, Yuelin Zhang, Caizhong Lu, Zhongsheng Chang, Guangjian Jiang
  Heliyon.2024; 10(13): e33601.     CrossRef
• Improvement of Cardiac Function and Subcellular Defects Due to Chronic Diabetes upon Treatment with Sarpogrelate
  Paramjit S. Tappia, Vijayan Elimban, Anureet K. Shah, Ramesh K. Goyal, Naranjan S. Dhalla
  Journal of Cardiovascular Development and Disease.2024; 11(7): 215.     CrossRef
• Progress of Mitochondrial Kinetics in Ejection Fraction Preserving Heart Failure
  梦茹 胡
  Advances in Clinical Medicine.2024; 14(07): 945.     CrossRef
• Molecular Basis of Cardiomyopathies in Type 2 Diabetes
  Silvia Giardinelli, Giovanni Meliota, Donatella Mentino, Gabriele D’Amato, Maria Felicia Faienza
  International Journal of Molecular Sciences.2024; 25(15): 8280.     CrossRef
• Exendin-4 exhibits cardioprotective effects against high glucose-induced mitochondrial abnormalities: Potential role of GLP-1 receptor and mTOR signaling
  Warisara Parichatikanond, Sudhir Pandey, Supachoke Mangmool
  Biochemical Pharmacology.2024; 229: 116552.     CrossRef
• Therapeutic potential of finerenone for diabetic cardiomyopathy: focus on the mechanisms
  Jing Wang, Haojie Xue, Jinyu He, Li Deng, Julong Tian, Yang Jiang, Jian Feng
  Diabetology & Metabolic Syndrome.2024;[Epub]     CrossRef
• Targeting DUSP26 to drive cardiac mitochondrial dynamics via FAK-ERK signaling in diabetic cardiomyopathy
  Chong Liu, Xiangli Xu, Guiming Sun, Chengchao Song, Shuangquan Jiang, Ping Sun, Jiawei Tian
  Free Radical Biology and Medicine.2024; 225: 856.     CrossRef
• Cellular interplay between cardiomyocytes and non-myocytes in diabetic cardiomyopathy
  Ren Jie Phang, Rebecca H Ritchie, Derek J Hausenloy, Jarmon G Lees, Shiang Y Lim
  Cardiovascular Research.2023; 119(3): 668.     CrossRef
• Mitochondrial miRNA as epigenomic signatures: Visualizing aging-associated heart diseases through a new lens
  Jasvinder Singh Bhatti, Naina Khullar, Rajesh Vijayvergiya, Umashanker Navik, Gurjit Kaur Bhatti, P. Hemachandra Reddy
  Ageing Research Reviews.2023; 86: 101882.     CrossRef
• Eucommiae Folium and Active Compounds Protect Against Mitochondrial Dysfunction-Calcium Overload in Epileptic Hippocampal Neurons Through the Hypertrophic Cardiomyopathy Pathway
  Shuai-nan Zhang, Hong-mei Li, Qi Liu, Xu-zhao Li, Wu-de Yang, Ying Zhou
  Neurochemical Research.2023; 48(9): 2674.     CrossRef
• Speckle-tracking echocardiography provides sensitive measurements of subtle early alterations associated with cardiac dysfunction in T2DM rats
  Yanchao Qi, Zhiyan Chen, Bingyan Guo, Zhe Liu, Lijie Wang, Suyun Liu, Lixiang Xue, Meifang Ma, Yajuan Yin, Yongjun Li, Gang Liu
  BMC Cardiovascular Disorders.2023;[Epub]     CrossRef
• Novel insights into the role of mitochondria in diabetic cardiomyopathy: molecular mechanisms and potential treatments
  Fumin Zhi, Qian Zhang, Li Liu, Xing Chang, Hongtao Xu
  Cell Stress and Chaperones.2023; 28(6): 641.     CrossRef
• Transcription factor EB: A potential integrated network regulator in metabolic-associated cardiac injury
  Weixing Wen, Haoxiao Zheng, Weiwen Li, Guolin Huang, Peng Chen, Xiaolin Zhu, Yue Cao, Jiahuan Li, Xiaohui Huang, Yuli Huang
  Metabolism.2023; 147: 155662.     CrossRef
• Role of STIM1 in the Regulation of Cardiac Energy Substrate Preference
  Panpan Liu, Zhuli Yang, Youjun Wang, Aomin Sun
  International Journal of Molecular Sciences.2023; 24(17): 13188.     CrossRef
• Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer
  Carmine Rocca, Teresa Soda, Ernestina Marianna De Francesco, Marco Fiorillo, Francesco Moccia, Giuseppe Viglietto, Tommaso Angelone, Nicola Amodio
  Journal of Translational Medicine.2023;[Epub]     CrossRef
• Triarylphosphonium compounds as effective vectors for mitochondria-targeted delivery systems: decoration strategies and prospects for clinical application
  T. N. Pashirova, A. V. Nemtarev, E. B. Souto, V. F. Mironov
  Russian Chemical Reviews.2023; 92(10): RCR5095.     CrossRef
• Moderate- and High-Intensity Endurance Training Alleviate Diabetes-Induced Cardiac Dysfunction in Rats
  Sarah D’Haese, Maxim Verboven, Lize Evens, Dorien Deluyker, Ivo Lambrichts, BO Eijnde, Dominique Hansen, Virginie Bito
  Nutrients.2023; 15(18): 3950.     CrossRef
• Alpha-lipoic acid enhances ischemic postconditioning-mediated improvement of myocardial infarction and apoptosis in diabetic rats with ischemia/reperfusion injury
  Sanaz Gholami, Reza Badalzadeh, Alireza Alihemmati
  Canadian Journal of Physiology and Pharmacology.2023; 101(12): 682.     CrossRef
• Concurrent diabetes and heart failure: interplay and novel therapeutic approaches
  Qutuba G Karwi, Kim L Ho, Simran Pherwani, Ezra B Ketema, Qiuyu Sun, Gary D Lopaschuk
  Cardiovascular Research.2022; 118(3): 686.     CrossRef
• Ca2+ mishandling and mitochondrial dysfunction: a converging road to prediabetic and diabetic cardiomyopathy
  Carolina Jaquenod De Giusti, Julieta Palomeque, Alicia Mattiazzi
  Pflügers Archiv - European Journal of Physiology.2022; 474(1): 33.     CrossRef
• Double-edge sword roles of iron in driving energy production versus instigating ferroptosis
  Shuping Zhang, Wei Xin, Gregory J. Anderson, Ruibin Li, Ling Gao, Shuguang Chen, Jiajun Zhao, Sijin Liu
  Cell Death & Disease.2022;[Epub]     CrossRef
• Differential remodelling of mitochondrial subpopulations and mitochondrial dysfunction are a feature of early stage diabetes
  Bodour S. Rajab, Sarah Kassab, Connor D. Stonall, Hussam Daghistani, Stephen Gibbons, Mamas Mamas, David Smith, Aleksandr Mironov, Zainab AlBalawi, Yin Hua Zhang, Florence Baudoin, Min Zi, Sukhpal Prehar, Elizabeth J. Cartwright, Ashraf Kitmitto
  Scientific Reports.2022;[Epub]     CrossRef
• GlyNAC (Glycine and N-Acetylcysteine) Supplementation Improves Impaired Mitochondrial Fuel Oxidation and Lowers Insulin Resistance in Patients with Type 2 Diabetes: Results of a Pilot Study
  Rajagopal V. Sekhar
  Antioxidants.2022; 11(1): 154.     CrossRef
• Glucose-derived posttranslational modification in cardiovascular disease
  Michael Lehrke, Julia Moellmann, Florian Kahles, Nikolaus Marx
  Molecular Aspects of Medicine.2022; 86: 101084.     CrossRef
• Mitochondrial Implications in Cardiovascular Aging and Diseases: The Specific Role of Mitochondrial Dynamics and Shifts
  Anastasia V. Poznyak, Tatiana V. Kirichenko, Evgeny E. Borisov, Nikolay K. Shakhpazyan, Andrey G. Kartuesov, Alexander N. Orekhov
  International Journal of Molecular Sciences.2022; 23(6): 2951.     CrossRef
• Editorial: Management of Diabetes and its Complications: A Focus on Endothelial Dysfunction
  Shanhu Qiu, Jianhua Ma, Tongzhi Wu
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Alternative autophagy: mechanisms and roles in different diseases
  Hong Feng, Nian Wang, Nan Zhang, Hai-han Liao
  Cell Communication and Signaling.2022;[Epub]     CrossRef
• Mitochondria-Mediated Cardiovascular Benefits of Sodium-Glucose Co-Transporter 2 Inhibitors
  Siarhei A. Dabravolski, Alexander D. Zhuravlev, Andrey G. Kartuesov, Evgeny E. Borisov, Vasily N. Sukhorukov, Alexander N. Orekhov
  International Journal of Molecular Sciences.2022; 23(10): 5371.     CrossRef
• Animal Models of Dysregulated Cardiac Metabolism
  Heiko Bugger, Nikole J. Byrne, E. Dale Abel
  Circulation Research.2022; 130(12): 1965.     CrossRef
• Mitochondrial Dynamics and Mitophagy in Cardiometabolic Disease
  Jianguo Lin, Jinlong Duan, Qingqing Wang, Siyu Xu, Simin Zhou, Kuiwu Yao
  Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
• Perspectives for Forkhead box transcription factors in diabetic cardiomyopathy: Their therapeutic potential and possible effects of salvianolic acids
  Ronghui Han, Hemeng Huang, Weiyi Xia, Jingjin Liu, Hui Luo, Jing Tang, Zhengyuan Xia
  Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
• Molecular and cellular mechanisms in diabetic heart failure: Potential therapeutic targets
  Misganaw Asmamaw Mengstie, Endeshaw Chekol Abebe, Awgichew Behaile Teklemariam, Anemut Tilahun Mulu, Assefa Agegnehu Teshome, Edgeit Abebe Zewde, Zelalem Tilahun Muche, Muluken Teshome Azezew
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Effect of Chronic Treatment with Uridine on Cardiac Mitochondrial Dysfunction in the C57BL/6 Mouse Model of High-Fat Diet–Streptozotocin-Induced Diabetes
  Natalia V. Belosludtseva, Vlada S. Starinets, Irina B. Mikheeva, Maxim N. Belosludtsev, Mikhail V. Dubinin, Galina D. Mironova, Konstantin N. Belosludtsev
  International Journal of Molecular Sciences.2022; 23(18): 10633.     CrossRef
• FGF21–Sirtuin 3 Axis Confers the Protective Effects of Exercise Against Diabetic Cardiomyopathy by Governing Mitochondrial Integrity
  Leigang Jin, Leiluo Geng, Lei Ying, Lingling Shu, Kevin Ye, Ranyao Yang, Yan Liu, Yao Wang, Yin Cai, Xue Jiang, Qin Wang, Xingqun Yan, Boya Liao, Jie Liu, Fuyu Duan, Gary Sweeney, Connie Wai Hong Woo, Yu Wang, Zhengyuan Xia, Qizhou Lian, Aimin Xu
  Circulation.2022; 146(20): 1537.     CrossRef
• Novel Insights Into Molecular Mechanism of Mitochondria in Diabetic Cardiomyopathy
  Jing Bai, Chuanbin Liu, Pingjun Zhu, Yang Li
  Frontiers in Physiology.2021;[Epub]     CrossRef
• Mitochondrial Dysfunction Increases Arrhythmic Triggers and Substrates; Potential Anti-arrhythmic Pharmacological Targets
  Khalil Saadeh, Ibrahim Talal Fazmin
  Frontiers in Cardiovascular Medicine.2021;[Epub]     CrossRef
• Prostaglandin E receptor subtype 4 protects against diabetic cardiomyopathy by modulating cardiac fatty acid metabolism via FOXO1/CD36 signalling
  Fan Ying, Hao Liu, Eva Hoi Ching Tang, Ishan Lakhani, Ningning Liu, Zhengyuan Xia, Shiming Liu
  Biochemical and Biophysical Research Communications.2021; 548: 196.     CrossRef
• Study of long non-coding RNA and mitochondrial dysfunction in diabetic rats
  Haytham K. Sultan, Wael M. El-Ayat, Azza H. AbouGhalia, Noha N. Lasheen, Amr S. Moustafa
  Tissue and Cell.2021; 71: 101516.     CrossRef
• A Role of Glucose Overload in Diabetic Cardiomyopathy in Nonhuman Primates
  Xiu Wang, Shi Jin, Weina Hu, Gaetano Santulli
  Journal of Diabetes Research.2021; 2021: 1.     CrossRef
• Dysregulation of circulating miRNAs promotes the pathogenesis of diabetes-induced cardiomyopathy
  Uzair Ahmed, Usman Ali Ashfaq, Muhammad Qasim, Imtiaz Ahmad, Hafiz Usman Ahmad, Muhammad Tariq, Muhammad Shareef Masoud, Saba Khaliq, Muhammad Younas Khan Barozai
  PLOS ONE.2021; 16(4): e0250773.     CrossRef
• MicroRNAs Regulating Mitochondrial Function in Cardiac Diseases
  Guang-Qiong Zhang, Sheng-Quan Wang, Yan Chen, Ling-Yun Fu, Yi-Ni Xu, Ling Li, Ling Tao, Xiang-Chun Shen
  Frontiers in Pharmacology.2021;[Epub]     CrossRef
• Effects of omega-3 fatty acids and metformin combination on diabetic cardiomyopathy in rats through autophagic pathway
  Salma M. Eraky, Nehal M. Ramadan
  The Journal of Nutritional Biochemistry.2021; 97: 108798.     CrossRef
• Adropin Alleviates Myocardial Fibrosis in Diabetic Cardiomyopathy Rats: A Preliminary Study
  Mao Liu, Jiao Ai, Zhuang Shuai, Kai Tang, Zongyu Li, Yin Huang
  Frontiers in Cardiovascular Medicine.2021;[Epub]     CrossRef
• Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities
  Izabela Tuleta, Nikolaos G. Frangogiannis
  Advanced Drug Delivery Reviews.2021; 176: 113904.     CrossRef
• Effect of the MPT Pore Inhibitor Alisporivir on the Development of Mitochondrial Dysfunction in the Heart Tissue of Diabetic Mice
  Natalia V. Belosludtseva, Vlada S. Starinets, Irina B. Mikheeva, Dmitriy A. Serov, Maxim E. Astashev, Maxim N. Belosludtsev, Mikhail V. Dubinin, Konstantin N. Belosludtsev
  Biology.2021; 10(9): 839.     CrossRef
• Characterisation of the Myocardial Mitochondria Structural and Functional Phenotype in a Murine Model of Diabetic Cardiomyopathy
  Alex M. Parker, Mitchel Tate, Darnel Prakoso, Minh Deo, Andrew M. Willis, David M. Nash, Daniel G. Donner, Simon Crawford, Helen Kiriazis, Cesare Granata, Melinda T. Coughlan, Miles J. De Blasio, Rebecca H. Ritchie
  Frontiers in Physiology.2021;[Epub]     CrossRef
• Radiation‑induced dysfunction of energy metabolism in the heart results in the fibrosis of cardiac tissues
  Peng Xu, Yali Yi, Yijing Luo, Zhicheng Liu, Yilin Xu, Jing Cai, Zhimin Zeng, Anwen Liu
  Molecular Medicine Reports.2021;[Epub]     CrossRef
• Heart Failure and Diabetes: Perspective of a Dangerous Association
  Liliana E. Favaloro, Roxana D. Ratto, Carla Musso
  Current Hypertension Reviews.2021; 17(2): 85.     CrossRef
• CTRP9 Mediates Protective Effects in Cardiomyocytes via AMPK- and Adiponectin Receptor-Mediated Induction of Anti-Oxidant Response
  Bernd Niemann, Ling Li, Dorothee Siegler, Benedikt H. Siegler, Fabienne Knapp, Jakob Hanna, Muhammad Aslam, Michael Kracht, Rainer Schulz, Susanne Rohrbach
  Cells.2020; 9(5): 1229.     CrossRef
• The Hippo Pathway Orchestrates Mitochondrial Quality Control: A Novel Focus on Cardiovascular Diseases
  Ying Tan, Cai Lei, Huifang Tang, Xiao Zhu, Guanghui Yi
  DNA and Cell Biology.2020; 39(9): 1494.     CrossRef
• Adeno-Associated Viral Transfer of Glyoxalase-1 Blunts Carbonyl and Oxidative Stresses in Hearts of Type 1 Diabetic Rats
  Fadhel A. Alomar, Abdullah Al-Rubaish, Fahad Al-Muhanna, Amein K. Al-Ali, JoEllyn McMillan, Jaipaul Singh, Keshore R. Bidasee
  Antioxidants.2020; 9(7): 592.     CrossRef
• Loss of function of transcription factor EB remodels lipid metabolism and cell death pathways in the cardiomyocyte
  Purvi C. Trivedi, Jordan J. Bartlett, Angella Mercer, Logan Slade, Marc Surette, Andrea Ballabio, Stephane Flibotte, Bahira Hussein, Brian Rodrigues, Petra C. Kienesberger, Thomas Pulinilkunnil
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2020; 1866(10): 165832.     CrossRef
• Rescue of myocardial energetic dysfunction in diabetes through the correction of mitochondrial hyperacetylation by honokiol
  Matthew Kerr, Jack J. Miller, Dharendra Thapa, Sophie Stiewe, Kerstin N. Timm, Claudia N. Montes Aparicio, Iain Scott, Damian J. Tyler, Lisa C. Heather
  JCI Insight.2020;[Epub]     CrossRef
• Diabetes Mellitus, Mitochondrial Dysfunction and Ca2+-Dependent Permeability Transition Pore
  Konstantin N. Belosludtsev, Natalia V. Belosludtseva, Mikhail V. Dubinin
  International Journal of Molecular Sciences.2020; 21(18): 6559.     CrossRef
• Effects of Standardized Green Tea Extract and Its Main Component, EGCG, on Mitochondrial Function and Contractile Performance of Healthy Rat Cardiomyocytes
  Rocchina Vilella, Gianluca Sgarbi, Valeria Naponelli, Monia Savi, Leonardo Bocchi, Francesca Liuzzi, Riccardo Righetti, Federico Quaini, Caterina Frati, Saverio Bettuzzi, Giancarlo Solaini, Donatella Stilli, Federica Rizzi, Alessandra Baracca
  Nutrients.2020; 12(10): 2949.     CrossRef
• Diabetic cardiomyopathy: definition, diagnosis criteria, treatment directions and prevention of heart failure
  N. A. Koziolova, P. G. Karavaev, A. S. Veklich
  South Russian Journal of Therapeutic Practice.2020; 1(2): 93.     CrossRef
• Adiponectin protects HL-1 cardiomyocytes against rotenone-induced cytotoxicity through AMPK activation
  Biao Li, Baojian Zhang, Na Liu, Keke Wu, Yingxu Ma, Wanyun Zuo, Zuodong Ning, Yaozhong Liu, Chao Sun, Yichao Xiao, Tao Tu, Qiming Liu
  Toxicology Letters.2020; 335: 82.     CrossRef
• Nutrient Sensor mTOR and OGT: Orchestrators of Organelle Homeostasis in Pancreatic β-Cells
  Nicholas Esch, Seokwon Jo, Mackenzie Moore, Emilyn U. Alejandro, Yingke Xu
  Journal of Diabetes Research.2020; 2020: 1.     CrossRef
• Where Does Metformin Stand in Modern Day Management of Type 2 Diabetes?
  Ehtasham Ahmad, Jack Sargeant, Francesco Zaccardi, Kamlesh Khunti, David Webb, Melanie Davies
  Pharmaceuticals.2020; 13(12): 427.     CrossRef